Skip to main content
logo
VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.5572
-0.0024 (-0.44%)
At close: Feb 9, 2026, 4:00 PM EST
0.5575
+0.0003 (0.06%)
After-hours: Feb 9, 2026, 4:10 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 Dec '17 Dec '16
Chronic Inflammatory and Immune-mediated Therapies
501.00K
Chronic Inflammatory and Immune-mediated Therapies Growth
18.16%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 Dec '17 Dec '16
United States
501.00K
United States Growth
18.16%